From the Department of Radiology, Division of Oncologic Imaging (R.G.F., S.B.G.), and Department of Radiation Oncology (A.M.C.C., A.G.C.), Hospital Clínico Universitario de Santiago de Compostela, Choupana s/n, 15706 Santiago de Compostela, Spain; Department of Advanced Medical Imaging, Grupo Health Time, Sercosa (Servicio Radiologia Computerizada, Clínica Las Nieves, Jaén, Spain (A.L.); Paul Strickland Scanner Centre, Mount Vernon Cancer Centre, Northwood, Middlesex, England (A.R.P.); Department of Radiology, Clínica Girona and Hospital Santa Caterina, Girona, Spain (J.C.V.); Department of Radiology, Hospital Clínic Barcelona, Barcelona, Spain (L.O.Z.); Unidad de Gestión Clínica de Medicina Nuclear, Instituto Maimónides de Investigación Biomédica de Córdoba, Hospital Universitario Reina Sofía, Córdoba, Spain (J.A.V.C.); and Department of Radiology, Instituto Valenciano de Oncología, Valencia, Spain (A.M.).
Radiographics. 2024 Feb;44(2):e230152. doi: 10.1148/rg.230152.
Radiation therapy is fundamental in the treatment of cancer. Imaging has always played a central role in radiation oncology. Integrating imaging technology into irradiation devices has increased the precision and accuracy of dose delivery and decreased the toxic effects of the treatment. Although CT has become the standard imaging modality in radiation therapy, the development of recently introduced next-generation imaging techniques has improved diagnostic and therapeutic decision making in radiation oncology. Functional and molecular imaging techniques, as well as other advanced imaging modalities such as SPECT, yield information about the anatomic and biologic characteristics of tumors for the radiation therapy workflow. In clinical practice, they can be useful for characterizing tumor phenotypes, delineating volumes, planning treatment, determining patients' prognoses, predicting toxic effects, assessing responses to therapy, and detecting tumor relapse. Next-generation imaging can enable personalization of radiation therapy based on a greater understanding of tumor biologic factors. It can be used to map tumor characteristics, such as metabolic pathways, vascularity, cellular proliferation, and hypoxia, that are known to define tumor phenotype. It can also be used to consider tumor heterogeneity by highlighting areas at risk for radiation resistance for focused biologic dose escalation, which can impact the radiation planning process and patient outcomes. The authors review the possible contributions of next-generation imaging to the treatment of patients undergoing radiation therapy. In addition, the possible roles of radio(geno)mics in radiation therapy, the limitations of these techniques, and hurdles in introducing them into clinical practice are discussed. RSNA, 2024 Test Your Knowledge questions for this article are available in the supplemental material.
放射治疗是癌症治疗的基础。影像学在放射肿瘤学中一直起着核心作用。将成像技术集成到照射设备中,提高了剂量输送的精度和准确性,降低了治疗的毒性作用。虽然 CT 已成为放射治疗的标准成像方式,但新一代成像技术的发展提高了放射肿瘤学的诊断和治疗决策水平。功能和分子成像技术以及 SPECT 等其他先进的成像方式,为放射治疗工作流程提供了有关肿瘤解剖和生物学特征的信息。在临床实践中,它们可用于表征肿瘤表型、划定肿瘤体积、规划治疗、确定患者预后、预测毒性作用、评估治疗反应以及检测肿瘤复发。下一代成像技术可以根据对肿瘤生物学因素的更深入了解,实现放射治疗的个体化。它可用于绘制肿瘤特征图谱,如代谢途径、血管生成、细胞增殖和缺氧等,这些都已知可以定义肿瘤表型。它还可以通过突出对放射抵抗有风险的区域,用于聚焦生物学剂量升级,从而考虑肿瘤异质性,这可能会影响放射治疗计划和患者的治疗结果。作者综述了下一代成像技术在接受放射治疗的患者治疗中的可能贡献。此外,还讨论了放射(基因)组学在放射治疗中的可能作用、这些技术的局限性以及将其引入临床实践的障碍。本文的 RSNA2024 知识测试问题可在补充材料中找到。